Trials / Active Not Recruiting
Active Not RecruitingNCT07339735
A Study of LY4064809 in Healthy Adult Participants
A Phase 1, Open-Label Study to Assess the Relative Bioavailability of Two LY4064809 Formulations in Healthy Adult Participants
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to find out how much LY4064809 gets into the blood stream and how long it takes the body to get rid of it when it is given as two formulations. For each participant, the study will last about nine weeks. Participants will remain in the clinical research center for about one month.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY4064809 Test Formulation | Administered orally |
| DRUG | LY4064809 Reference Formulation | Administered orally |
Timeline
- Start date
- 2026-01-12
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2026-01-14
- Last updated
- 2026-03-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07339735. Inclusion in this directory is not an endorsement.